2023
DOI: 10.1007/s44164-022-00040-x
|View full text |Cite
|
Sign up to set email alerts
|

3D spheroid culture to examine adaptive therapy response in invading tumor cells

Abstract: 3D in vitro culture models of cancer cells in extracellular matrix (ECM) have been developed to investigate drug targeting and resistance or, alternatively, mechanisms of invasion; however, models allowing analysis of shared pathways mediating invasion and therapy resistance are lacking. To evaluate therapy response associated with cancer cell invasion, we here used 3D invasion culture of tumor spheroids in 3D fibrillar collagen and applied Ethanol-Ethyl cinnamate (EtOH-ECi) based optical clearing to detect bo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Accordingly, novel biomodulatory combinations may be established and drug repurposing exploited, particularly with respect to edited non-oncogene addiction ( Table 1 , Figure 1 ) [ 37 , 147 ]. Molecular imaging, imaging-based 3D invasion culture, imaging mass cytometry and ‘omic’ technologies could be pivotal techniques for studying mechanisms involved in providing therapeutically relevant tumor plasticity and for guiding the appropriate selection of biomodulatory active drugs addressing the M-CRAC problem ( Figure 4 ) [ 148 , 149 , 150 , 151 , 152 ].…”
Section: Addressing M-crac Control With a Novel Therapy Model For R/r...mentioning
confidence: 99%
“…Accordingly, novel biomodulatory combinations may be established and drug repurposing exploited, particularly with respect to edited non-oncogene addiction ( Table 1 , Figure 1 ) [ 37 , 147 ]. Molecular imaging, imaging-based 3D invasion culture, imaging mass cytometry and ‘omic’ technologies could be pivotal techniques for studying mechanisms involved in providing therapeutically relevant tumor plasticity and for guiding the appropriate selection of biomodulatory active drugs addressing the M-CRAC problem ( Figure 4 ) [ 148 , 149 , 150 , 151 , 152 ].…”
Section: Addressing M-crac Control With a Novel Therapy Model For R/r...mentioning
confidence: 99%